News
Results of the VANISH-2 trial, building on prior research, further upheld superiority of catheter ablation over ...
Although long-term oral amiodarone therapy does not increase mortality and may improve mortality in some patients, noncardiac toxicity is a major problem. In randomized trials, 41% of patients ...
SINGAPORE – A 41-year-old Singaporean man was arrested on April 16 at Woodlands Checkpoint after he was caught with a large amount of illegal drugs while riding in a Malaysian-registered car.
And we know there's been supply constraints. Making the injectable medications is difficult, technically hard and expensive," Ricks said. "And this will be easier to make at scale. And so patients ...
PORTLAND Ore. (KPTV) - The owner of a local money service business was arrested this week and is facing federal charges of money laundering involving drug cartels. On Wednesday, federal ...
"Through investigative efforts, an undercover State Trooper was able to successfully conduct nine controlled drug purchases with a member of the drug trafficking organization," the release said.
Patients who take a common drug for high blood pressure are being urged to check the medication after its manufacturer reported that a mistake in the strength of the dose had been printed on some ...
Daniel Warren, Declan Jones and Wesley Curtis were caught flooding the streets of Blaenau Gwent with the class A drug. They pleaded guilty to conspiracy to supply cocaine. The trio were back in ...
Now, let's get to the news: Blue Cross Blue Shield of Massachusetts, the state's largest commercial health insurer, is rolling back its coverage of GLP-1 drugs like Ozempic and Wegovy for weight loss.
Summary: A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and increased risk of depression and suicidal ideation, especially in people ...
This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...
French drugmaker Sanofi agreed to pay $125 million to startup Earendil Labs for two drug candidates designed to treat autoimmune and inflammatory bowel diseases. Under the terms of the deal announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results